Matrilysin-dependent elastolysis by human macrophages

Journal of Experimental Medicine

Volumn 198, Issue 6, 2003, Pages 925-935

  Filippov, Sergey ^a   Caras, Ingrid ^b   Murray, Richard ^b   Matrisian, Lynn M ^c   Chapman Jr , Harold A ^d   Shapiro, Steven ^e   Weiss, Stephen J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b Eos Biotechnology   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

Cysteine proteinase; Elastin; Macrophage; Matrix metalloproteinase; Plasminogen

Indexed keywords

CHEMOKINE; CYSTEINE PROTEINASE; ELASTIN; ENZYME PRECURSOR; GELATINASE B; GROWTH FACTOR; MATRILYSIN; MATRIX METALLOPROTEINASE; PROGELATINASE B; PROMATRILYSIN; PROMETALLOELASTASE; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ELASTOLYSIS; ENZYME MECHANISM; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VIVO STUDY; MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; UPREGULATION;

ANIMALS; AORTA; CATHEPSINS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; ELASTIN; ENZYME INHIBITORS; HUMANS; MACROPHAGES; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC ELASTASE; PLASMINOGEN; PLASMINOGEN ACTIVATORS;

EID: 0141449964     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030626     Document Type: Article

References (44)

1. Galis, Z.S., G.K. Sukhova, M.W. Lark., and P. Libby. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:2493-2503.
2. Halpert, I., U.I. Sires, J.D. Roby, S. Potter-Perigo, T.N. Wight, S.D. Shapiro, H.G. Welgus, S.A. Wickline, and W.C. Parks. 1996. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc. Natl. Acad. Sci. USA. 93:9748-9753.
3. Hautamaki, R.D., D.K. Kobayashi, R.M. Senior, and S.D. Shapiro. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 277: 2002-2004.
4. Curci, J.A., S. Liao, M.D. Huffman, S.D. Shapiro, and R.W. Thompson. 1998. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J. Clin. Invest. 102:1900-1910.
5. Carmeliet, P., L. Moons, R. Lijnen, M. Baes, V. Lemaitre, P. Tipping, A. Drew, Y. Eeckhout, S. Shapiro, F. Lupu, and D. Collen. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17:439-444.
6. Heymans, S., A. Luttun, D. Nuyens, G. Theilmeier, E. Creemers, L. Moons, G.D. Dyspersin, J.P.M. Cleutjens, M. Shipley, A. Angellilo, et al. 1999. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat. Med. 5:1135-1142.
7. Pyo, R., J.K. Lee, J.M. Shipley, J.A. Curci, D. Mao, S.J. Ziporin, T.L. Ennis, S.D. Shapiro, R.M. Senior, and R.W. Thompson. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105: 1641-1649.
8. Longo, G.M., W. Xiong, T.C. Greiner, Y. Zhao, N. Fiotti, and B.T. Baxter. 2002. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110:625-632.
9. Parks, W.C. 2002. A confederacy of proteinases. J. Clin. Invest. 110:613-614.
10. Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2:161-174.
11. Lopez-Otin, C., and C.M. Overall. 2002. Protease degradomics: a new challenge for proteomics. Nat. Rev. Mol. Cell Biol. 3:509-519.
12. Chapman, H.A., Jr., O.L. Stone, and Z. Vavrin. 1984. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation. J. Clin. Invest. 73:806-815.
13. Chapman, H.A., Jr., and O.L. Stone. 1984. Comparison of live human neutrophil and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors. J. Clin. Invest. 74:1693-1700.
14. Senior, R.M., N.L. Connolly, J.D., Cury, H.G. Welgus, and E.J. Campbell. 1989. Elastin degradation by human alveolar macrophages. Am. Rev. Respir. Dis. 139:1251-1256.
15. Reddy, V.Y., Q.Y. Zhang, and S.J. Weiss. 1995. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA. 92:3849-3853.
16. Punturieri, A., S. Filippov, E. Allen, I. Caras, R. Murray, V. Reddy, and S.J. Weiss. 2000. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J. Exp. Med. 192:789-799.
17. Geissmann F., P. Revy, A. Regnault, Y. Lepelletier, M. Dy, N. Brousse, S. Amigorena, O. Hermine, and A. Durandy. 1999. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162:4567-4575.
18. Tammi, R.H., M.I. Tammi, V.C. Hascall, M. Hogg, S. Pasonen, and D.K. MacCallum. 2000. A preformed basal lamina alters the metabolism and distribution of hyaluronan in epidermal keratinocyte "organotypic" cultures grown on collagen matrices. Histochem. Cell Biol. 113:265-277.
19. Betsuyaku, T., J.M. Shipley, Z. Liu, and R.M. Senior. 1999. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. Am. J. Respir. Cell Mol. Biol. 20:1303-1309.
20. Gardell, S.J., L.T. Duong, R.E. Diehl, J.D. York, T.R. Hare, R.B. Register, J.W. Jacobs, R.A. Dixon, and P.A. Friedman. 1989. Isolation, characterization, and cDNA cloning of a vampire bat salivary plasminogen activator. J. Biol. Chem. 264:17947-17952.
21. Ramos-DeSimone, N., E. Hahn-Dantona, J. Sipley, H. Nagase, D.L. French, and J.P. Quigley. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem. 274:13066-13076.
22. Hotary, K.B., I. Yana, F. Sabeh, X.-Y. Li, K. Holmbeck, H. Birkedal-Hansen, E.D. Allen, N. Hiraoka, and S.J. Weiss. 2002. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J. Exp. Med. 195:295-308.
23. Hotary, K., E. Allen, A. Punturieri, I. Yana, and S.J. Weiss. 2000. Regulation of cell invasion and morphogenesis in a 3-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2 and 3. J. Cell Biol. 149:1309-1323.
24. Shattuck-Brandt, R.L., L.W. Lamps, K.J. Heppner Goss, R.N. DuBois, and L.M. Matrisian. 1999. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms. Mol. Carcinog. 24:177-187.
25. Knight, C.G., F. Willenbrock, and G. Murphy. 1992. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296:263-266.
26. Shankavaram, U.T., W.-C. Lai, S. Netzel-Arnett, P.R. Mangan, J.A. Ardans, N. Caterina, W.G. Stetler-Stevenson, H. Birkedal-Hansen, and L.M. Wahl. 2001. Monocyte membrane type 1-matrix metalloproteinase. J. Biol. Chem. 276: 19027-19032.
27. Lijnen, H.R., and D. Collen. 1999. Matrix metalloproteinase system deficiencies and matrix degradation. Thromb. Haemost. 82:837-845.
28. Brinckerhoff, C.E., and L.M. Matrisian. 2002. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 3:207-214.
29. Emonard, H., and W. Hornebeck. 1997. Binding of 92 kDa and 72 kDa progelatinases to insoluble elastin modulates their proteolytic activation. Biol. Chem. 378:265-271.
30. Bannikov, G.A., T.V. Karelina, I.E. Collier, B.L. Marmer, and G.I. Goldberg. 2002. Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J. Biol. Chem. 277:16022-16027.
31. 2. J. Exp. Med. 188:2257-2265.
32. Haro, H., H.C. Crawford, B. Fingleton, K. Shinomiya, D.M. Spengler, and L.M. Matrisian. 2000. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-α in a model of herniated disc resorption. J. Clin. Invest. 105:143-150.
33. Wilson, C.L., A.J. Ouellette, D.P. Satchell, T. Ayabe, Y.S. Lopez-Boado, J.L. Stratman, S.J. Hultgren, L.M. Matrisian, and W.C. Parks. 1999. Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science. 286:113-117.
34. Powell, W.C., B. Fingleton, C.L. Wilson, M., Boothby, and L.M. Matrisian. 1999. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr. Biol. 9:1441-1447.
35. Li, Q., P.W. Park, C.L. Wilson, and W.C. Parks. 2002. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell. 11:635-646.
36. Churg, A., R.D. Wang, H. Tai, X. Wang, C. Xie, J. Dai, S.D. Shapiro, and J.L. Wright. 2003. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via TNF-alpha release. Am. J. Respir. Crit. Care Med. 167:1083-1089.
37. Lanone, S., T. Zheng, A. Zhu, W. Liu, C.G. Lee, B. Ma, Q. Chen, R.J. Homer, J. Wang, L.A. Rabach, et al. 2002. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J. Clin. Invest. 110:463-474.
38. Mohan, R., S.K. Chintala, J.C. Jung, W.V.L. Villar, F. McCabe, L.A. Russo, Y. Lee, B.E. McCarthy, K.R. Wollenberg, J.V. Jester, et al. 2002. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J. Biol. Chem. 277:2065-2072.
39. Shipley, J.M., R.L. Wesselschmidt, D.K. Kobayashi, T.J. Ley, and S.D. Shapiro. 1996. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl. Acad. Sci. USA. 93:3942-3946.
40. Lehti, K., J. Lohi, M.M. Juntunen, D. Pei, and J. Keski-Oja. 2002. Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J. Biol. Chem. 277:8440-8448.
41. Thoma-Uszynski, S., S. Stenger, O. Takeuchi, M.T. Ochoa, M. Engele, P.A. Sieling, P.F. Barnes, M. Rollinghoff, P.L. Bolcskei, M. Wagner, et al. 2001. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science. 291:1544-1547.
42. Zheng, T., Z. Zhu, Z. Wang, R.J. Homer, B. Ma, R.J. Riese, Jr., H.A. Chapman, Jr., S.D. Shaprio, and J.A. Elias. 2000. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J. Clin. Invest. 106:1081-1093.
43. Zuo, F., N. Kaminski, E. Eugui, J. Allard, Z. Yakhini, A. Ben-Dor, L. Lollini, D. Morris, Y. Kim, B. DeLustro, et al. 2002. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc. Natl. Acad. Sci. USA. 99:6292-6297.
44. Sukhova, G.K., Y. Zhang, J.-H. Pan, Y. Wada, T. Yamamoto, M. Naito, T. Kodama, S. Tsimikas, J.L. Witztum, M.L. Lu, et al. 2003. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 111:897-906.